Carbidopa, Levodopa And Entacapone Tablet, Film Coated
Product Images NDC 46708-799

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Carbidopa, Levodopa And Entacapone (NDC 46708-799). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carbilevoent-12-5-50-200mg (Carbilevoent 12 5 50 200mg)

Label for Carbidopa, Levodopa and Entacapone tablets containing 12.5 mg Carbidopa USP, 50 mg Levodopa USP, and 200 mg Entacapone USP per film-coated tablet. The label includes storage instructions, manufacturer details (Alembic Pharmaceuticals Limited, India), a barcode, and warns against combining tablets to achieve higher strength due to overdose risk. Package contains 100 tablets for oral use.*

FDA Label Image

Carbilevoent-18-75-75-200mg (Carbilevoent 18 75 75 200mg)

Label for Carbidopa, Levodopa, and Entacapone Tablets by Alembic Pharmaceuticals Limited. Each film-coated tablet contains 18.75 mg Carbidopa USP, 75 mg Levodopa USP, and 200 mg Entacapone USP. The package contains 100 tablets with prescription-only status and storage instructions at 25°C (77°F), with excursions permitted between 15° to 30°C (59° to 86°F). Additional warnings include not crushing, splitting, or chewing the tablets.*

FDA Label Image

Carbilevoent-25-100-200mg (Carbilevoent 25 100 200mg)

Label for Carbidopa, Levodopa and Entacapone Tablets containing 25 mg Carbidopa USP, 100 mg Levodopa USP, and 200 mg Entacapone USP per film-coated tablet. The label includes storage instructions, manufacturer details (Alembic Pharmaceuticals Limited, India), and warnings about tablet strength combination. It indicates a 100-tablet count and notes child-resistant packaging and Rx only status.*

FDA Label Image

Carbilevoent-31-25-125-200mg (Carbilevoent 31 25 125 200mg)

Label for Carbidopa, Levodopa and Entacapone Tablets containing 31.25 mg carbidopa USP, 125 mg levodopa USP, and 200 mg entacapone USP per film-coated tablet. The label includes storage instructions, dosage advice to swallow whole, and manufacturer information for Alembic Pharmaceuticals Limited. The package contains 100 tablets.*

FDA Label Image

Carbilevoent-37-5-150-200 (Carbilevoent 37 5 150 200)

Label for Carbidopa, Levodopa and Entacapone Tablets, film-coated oral tablets containing 37.5 mg Carbidopa USP, 150 mg Levodopa USP, and 200 mg Entacapone USP per tablet. The label indicates a package size of 100 tablets and manufacturer as Alembic Pharmaceuticals Limited, Gujarat, India. It includes dosage instructions, storage conditions, and a barcode with NDC 46708-799-31.*

FDA Label Image

Carbilevoent-50-200-200mg (Carbilevoent 50 200 200mg)

Label for Carbidopa, Levodopa and Entacapone Tablets, film-coated, containing 50 mg carbidopa USP, 200 mg levodopa USP, and 200 mg entacapone USP per tablet. The label includes storage instructions, dosage guidance, manufacturer Alembic Pharmaceuticals Limited, and packaging of 100 tablets. Barcode and NDC 46708-800-31 are visible.*

FDA Label Image

Carbilevoenta-carbidopa.jpg (Carbilevoenta Carbidopa)

Chemical structure of carbidopa shown as a molecular diagram including hydroxyl groups, amide, and hydrazine functional groups, along with one water molecule (hydrate).*

FDA Label Image

Carbilevoenta-entacapone.jpg (Carbilevoenta Entacapone)

Chemical structure diagram of a molecule consistent with an active ingredient shown, featuring a nitro-substituted benzene ring with hydroxyl groups, a nitrile group, and an amide side chain.*

FDA Label Image

Carbilevoenta-levodopa.jpg (Carbilevoenta Levodopa)

Chemical structure of carbidopa, levodopa and entacapone, showing the molecular arrangement of atoms and bonds including hydroxyl groups, an amine, and a carboxyl group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.